Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-06

Clinical Trial Update: Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating sulfadoxine-pyrimethamine plus dihydroartemisinin-piperaquine for intermittent preventive treatm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)
  • Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: Menzies School of Health Research | Conditions: Malaria, Malaria in Pregnancy | Phase 3 | Status: ACTIVE_NOT_RECRUITING